Notably, further exploration of treating pancreatic cancers revealed that ubiquitin specific protease 34 (USP34) knockdown inhibited proliferation and migration, and induced apoptosis targeting PRR11 [55]. This evidence concerns the gene USP34 and pancreatic neoplasm.